Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors

There have been few reports of a response to dasatinib or nilotinib after failure of two prior sequential tyrosine kinase inhibitors. We report the outcome of 82 chronic phase patients who received nilotinib or dasatinib as third-line alternative tyrosine kinase inhibitor therapy. Thirty-four patien...

詳細記述

保存先:
書誌詳細
主要な著者: Rossi, Antonella Russo, Breccia, Massimo, Abruzzese, Elisabetta, Castagnetti, Fausto, Luciano, Luigiana, Gozzini, Antonella, Annunziata, Mario, Martino, Bruno, Stagno, Fabio, Cavazzini, Francesco, Tiribelli, Mario, Visani, Giuseppe, Pregno, Patrizia, Musto, Pellegrino, Fava, Carmen, Sgherza, Nicola, Albano, Francesco, Rosti, Gianantonio, Alimena, Giuliana, Specchia, Giorgina
フォーマット: Artigo
言語:Inglês
出版事項: Ferrata Storti Foundation 2013
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659922/
https://ncbi.nlm.nih.gov/pubmed/22801965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.064337
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料